
PulseData: Leveraging AI for early diagnosis and prevention in chronic kidney and heart diseases.
PulseData, founded with a mission to revolutionize healthcare through advanced AI, focuses on early diagnosis and prevention of chronic kidney and heart diseases. Their core vision is to drive preventive action, reduce medical costs, and eliminate patient suffering. PulseData offers predictive analytics software that leverages patented AI to diagnose, risk stratify, and predict adverse events in patients with chronic conditions. Their primary market includes healthcare providers and systems aiming to improve population health outcomes.
Notable affiliated individuals include leaders with extensive backgrounds in healthcare and technology. PulseData has garnered attention from investors interested in innovative health tech solutions. Key achievements include clinically-validated predictive insights that have significantly impacted patient care and cost savings. Overall, PulseData's AI-driven approach has made substantial strides in enhancing early diagnosis and preventive care in chronic disease management.

Health Data Analytics Institute
hda-institute.com

Impact Vitals
impactvitals.com

PotentiaMetrics

CognitiveCare
cognitivecare.com

Predictive Health Diagnostics Company

Heartio
heartio.ai

Predict Health
predicthealth.ai

Biocogniv

HealthTrends.AI
healthtrends.ai

nference
nference.net

Health at Scale
healthatscale.com

cliexa
cliexa.com

RAD AI
radai.com

Retina-Ai Health

ScienceIO
science.io
Companies similar to PulseData include Health Data Analytics Institute, Impact Vitals, PotentiaMetrics and CognitiveCare.
PulseData was founded in 2015.
PulseData's headquarters is located in New York City, NY, US.
PulseData's most recent funding round was for $16.5M (USD) in April 2021.
As of Apr 19, 2021, PulseData has raised a total of $19.7M (USD).
PulseData has 27 employees as of Feb 5, 2024.